Suplatast tosylate

CAS : 94055-76-2

Ref. 3D-FS27977

Informations sur le produit

• Nom: Suplatast tosylate
• Synonymes: [3-[[4-(3-ethoxy-2-hydroxypropoxy)phenyl]amino]-3-oxopropyl]dimethylsulfonium 4-methylbenzenesulfonate(±)-[2-[4-(3-Ethoxy-2-hydroxy propoxy)phenylcarbamoyl]ethyl]dimethylsulfonium p-toluenesulfonateIPD 1151T, (2-(4-(3-Ethoxy-2-Hydroxypropoxy)Phenylcarbamoyl)Ethyl)Dimethylsulfonium P-Toluenesulfonate, (3-{[4-(3-Ethoxy-2-Hydroxypropoxy)Phenyl]Amino}-3-Oxopropyl)(Dimethyl)Sulfonium 4-Methylbenzenesulfonate, Ipd 1151T, Sulfonium, [3-[[4-(3-ethoxy-2-hydroxypropoxy)phenyl]amino]-3-oxopropyl]dimethyl-, 4-methylbenzenesulfonate (1:1), Sulfonium, [3-[[4-(3-ethoxy-2-hydroxypropoxy)phenyl]amino]-3-oxopropyl]dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1), Suplatast tosilate

Description

Suplatast tosylate is an aldehyde-containing pentosan polysulfate sodium. It is a biocompatible polymer with a diameter of 400 nm and is used in the treatment of cancer. Suplatast tosylate has been shown to be effective against cervical cancer, which may be due to its ability to inhibit growth factor receptors. Suplatast tosylate also has anti-inflammatory properties and is used as an oral drug for the treatment of inflammatory diseases such as bladder inflammation or Crohn's disease. Suplatast tosylate can also be administered intravenously for the treatment of cancer or inflammatory diseases such as rheumatoid arthritis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 499.64 g/mol
• Formule: C₂₃H₃₃NO₇S₂
• Degré de pureté: Min. 95%